LT - 8-Heteroaril-3-alkil-1,3-dihidro-imidazo[4,5-c]chinolinonai, kaip Pl-3 kinazės inhibitoriai
EN - 8-heteroaryl-3-alkyl-1,3-dihydro-imidazo[4,5-c]quinolin-2-ones as PI-3 kinases inhibitors
Legal status
Patent lapsed (non-payment of fees)
Bibliographic data
Indications of the International Patent Classification (IPC)
| (51) |
INT.CL. |
C07D 471/04 |
(2006.01) |
|
|
A61K 31/4188 |
(2006.01) |
|
|
A61P 35/00 |
(2006.01) |
|
|
A61P 29/00 |
(2006.01) |
|
|
A61P 11/06 |
(2006.01) |
European patent
| (11) |
Number of the document |
2270008 |
| (13) |
Kind of document |
T |
| (96) |
European patent application number |
10175375.4 |
|
Date of filing the European patent application |
2006-05-18 |
| (97) |
Date of publication of the European application |
2011-01-05 |
| (45) |
Date of publication and mention of the grant of the patent |
2012-10-03
|
| (46) |
Date of publication of the claims translation |
2013-02-25
|
Priority applications
| (30) |
Number |
Date |
Country code |
|
0510390 |
2005-05-20
|
GB |
Inventors
| (72) |
Garcia-Echeverria, Carlos, CH
Stauffer, Frédéric, CH
Furet, Pascal, FR
|
Grantee
| (73) |
Novartis AG,
Lichtstrasse 35, 4056 Basel,
CH
|
Attorney or representative
| (74) |
Jurga PETNIŪNAITĖ,
AAA Law, A. Goštauto g. 40B, Verslo centras "Dvyniai", LT-03163 Vilnius,
LT
|
Title
| (54) |
8-Heteroaril-3-alkil-1,3-dihidro-imidazo[4,5-c]chinolinonai, kaip Pl-3 kinazės inhibitoriai |
| |
8-heteroaryl-3-alkyl-1,3-dihydro-imidazo[4,5-c]quinolin-2-ones as PI-3 kinases inhibitors |
Last renewal fee
|
Payment date |
Validity (years) |
Amount |
|
2016-04-19 |
11 |
289.00
EUR
|
Legal status
|
Patent lapsed (non-payment of fees)
|
|
|
Invalidation date |
2017-05-18 |
